Clinical Trial Update: Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the safety and efficacy of GSK315234A in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GSK315234A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED